首页 > 最新文献

European journal of obstetrics, gynecology, and reproductive biology最新文献

英文 中文
Efficacy of pelvic floor muscle training combined with promestriene in improving pelvic floor dysfunction in middle-aged and elderly women: a retrospective study 盆底肌训练联合前泌素改善中老年妇女盆底功能障碍的回顾性研究
IF 1.9 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2026-03-01 Epub Date: 2026-01-31 DOI: 10.1016/j.ejogrb.2026.114987
Jia Shan
<div><h3>Objective</h3><div>To evaluate the efficacy of pelvic floor muscle training (PFMT) combined with intravaginal Promestriene, a local steroid hormone precursor that is converted within vaginal tissues into active estrogens and androgens with minimal systemic absorption, in middle-aged and elderly women with pelvic floor dysfunction (PFD) and to explore its effects on muscle strength recovery, tissue improvement, and urinary control enhancement.</div></div><div><h3>Methods</h3><div>This single-center retrospective case analysis included 166 middle-aged and elderly female patients who received pelvic floor rehabilitation between January 2020 and December 2023. Based on previous treatment regimens, patients were divided into an intervention group (PFMT combined with Promestriene, n = 82) and a control group (PFMT alone, n = 84). The intervention period was 6–8 weeks, and all patients underwent follow-up assessments before the intervention, at the end of the intervention, and at 3 months post-intervention. Primary outcome measures included pelvic floor muscle strength (Oxford grading scale, electromyographic maximum voluntary contraction), muscle endurance, urinary control function (International Consultation on Incontinence Questionnaire-Short Form [ICIQ-SF] score, pad test weight), and vaginal tissue health (Vaginal Health Index [VHI] score, with higher values indicating better vaginal tissue health, pH, epithelial thickness, and tissue elasticity). Secondary outcomes included quality of life scores (Pelvic Floor Impact Questionnaire-Short Form 7 [PFIQ-7], Female Sexual Function Index [FSFI], Pittsburgh Sleep Quality Index [PSQI]), pelvic organ support (Pelvic Organ Prolapse Quantification [POP-Q] measurements), and adverse events. Propensity score matching was employed for sensitivity analysis to control for confounding factors.</div></div><div><h3>Results</h3><div>The intervention group demonstrated significantly greater improvements in pelvic floor muscle strength, muscle endurance, and electromyographic parameters compared to the control group (all P < 0.01). Regarding urinary control, the ICIQ-SF score decreased by an average of 5.4 points from baseline in the intervention group versus 3.7 points in the control group (P < 0.001), with a correspondingly greater reduction in pad test weight. Vaginal tissue health indicators showed that intravaginal Promestriene significantly improved mucosal color, lubrication, epithelial thickness, and tissue elasticity, with a greater overall improvement in VHI total score compared to the control group (P < 0.001). Quality of life across various domains also showed more pronounced enhancement, particularly in FSFI satisfaction and sleep quality. Improvements in pelvic support structures, such as POP-Q points Aa and Ba, were more marked in the intervention group. The clinical response rate (defined as a ≥ 4-point improvement in ICIQ-SF) was 68.3% in the intervention group, significantly higher t
目的:评价盆底肌训练(PFMT)联合阴道内泌乳素(Promestriene)治疗中老年盆底功能障碍(PFD)的疗效,探讨其对肌肉力量恢复、组织改善和尿控增强的影响。Promestriene是一种局部类固醇激素前体,在阴道组织内转化为活性雌激素和雄激素,全身吸收最小。方法:本研究为单中心回顾性病例分析,纳入2020年1月至2023年12月期间接受盆底康复治疗的166例中老年女性患者。根据既往治疗方案,将患者分为干预组(PFMT联合Promestriene, n = 82)和对照组(PFMT单独治疗,n = 84)。干预期为6-8周,所有患者在干预前、干预结束时和干预后3个月均接受随访评估。主要结局指标包括盆底肌力(牛津分级量表、肌电图最大自愿收缩)、肌肉耐力、尿控制功能(国际失禁咨询问卷简表[ICIQ-SF]评分、尿垫试验重量)和阴道组织健康(阴道健康指数[VHI]评分,数值越高表明阴道组织健康、pH值、上皮厚度和组织弹性越好)。次要结局包括生活质量评分(盆底影响问卷-短表7 [PFIQ-7]、女性性功能指数[FSFI]、匹兹堡睡眠质量指数[PSQI])、盆腔器官支持(盆腔器官脱脱量化[POP-Q]测量)和不良事件。采用倾向评分匹配法进行敏感性分析,控制混杂因素。结果:干预组盆底肌力、肌肉耐力、肌电图参数均明显优于对照组(P < 0.01)。在尿控制方面,干预组ICIQ-SF评分比基线平均下降5.4分,对照组平均下降3.7分(P < 0.001),尿垫试验重量相应下降更大。阴道组织健康指标显示,阴道内泌乳素显著改善了粘膜颜色、润滑、上皮厚度和组织弹性,VHI总分的总体改善程度高于对照组(P < 0.001)。各个领域的生活质量也显示出更明显的提高,特别是在FSFI满意度和睡眠质量方面。盆腔支撑结构的改善,如POP-Q点Aa和Ba,在干预组更为明显。干预组临床有效率(以ICIQ-SF改善≥4分为标准)为68.3%,显著高于对照组的46.4% (P = 0.004)。在倾向评分匹配后,结果保持一致,表明强有力的发现。未观察到严重不良事件。结论:PFMT联合阴道内泌乳素对盆底功能障碍的中老年妇女有多方面的治疗效果,包括肌肉功能、尿控制、阴道组织状态和生活质量的改善。阴道内泌乳素通过改善局部组织微环境和激素状态来增强对盆底肌肉训练的反应性,是一种潜在的有价值的辅助干预措施。这种联合策略是安全可行的,为该人群的盆底康复提供了一种有希望的优化方法。
{"title":"Efficacy of pelvic floor muscle training combined with promestriene in improving pelvic floor dysfunction in middle-aged and elderly women: a retrospective study","authors":"Jia Shan","doi":"10.1016/j.ejogrb.2026.114987","DOIUrl":"10.1016/j.ejogrb.2026.114987","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;Objective&lt;/h3&gt;&lt;div&gt;To evaluate the efficacy of pelvic floor muscle training (PFMT) combined with intravaginal Promestriene, a local steroid hormone precursor that is converted within vaginal tissues into active estrogens and androgens with minimal systemic absorption, in middle-aged and elderly women with pelvic floor dysfunction (PFD) and to explore its effects on muscle strength recovery, tissue improvement, and urinary control enhancement.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Methods&lt;/h3&gt;&lt;div&gt;This single-center retrospective case analysis included 166 middle-aged and elderly female patients who received pelvic floor rehabilitation between January 2020 and December 2023. Based on previous treatment regimens, patients were divided into an intervention group (PFMT combined with Promestriene, n = 82) and a control group (PFMT alone, n = 84). The intervention period was 6–8 weeks, and all patients underwent follow-up assessments before the intervention, at the end of the intervention, and at 3 months post-intervention. Primary outcome measures included pelvic floor muscle strength (Oxford grading scale, electromyographic maximum voluntary contraction), muscle endurance, urinary control function (International Consultation on Incontinence Questionnaire-Short Form [ICIQ-SF] score, pad test weight), and vaginal tissue health (Vaginal Health Index [VHI] score, with higher values indicating better vaginal tissue health, pH, epithelial thickness, and tissue elasticity). Secondary outcomes included quality of life scores (Pelvic Floor Impact Questionnaire-Short Form 7 [PFIQ-7], Female Sexual Function Index [FSFI], Pittsburgh Sleep Quality Index [PSQI]), pelvic organ support (Pelvic Organ Prolapse Quantification [POP-Q] measurements), and adverse events. Propensity score matching was employed for sensitivity analysis to control for confounding factors.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Results&lt;/h3&gt;&lt;div&gt;The intervention group demonstrated significantly greater improvements in pelvic floor muscle strength, muscle endurance, and electromyographic parameters compared to the control group (all P &lt; 0.01). Regarding urinary control, the ICIQ-SF score decreased by an average of 5.4 points from baseline in the intervention group versus 3.7 points in the control group (P &lt; 0.001), with a correspondingly greater reduction in pad test weight. Vaginal tissue health indicators showed that intravaginal Promestriene significantly improved mucosal color, lubrication, epithelial thickness, and tissue elasticity, with a greater overall improvement in VHI total score compared to the control group (P &lt; 0.001). Quality of life across various domains also showed more pronounced enhancement, particularly in FSFI satisfaction and sleep quality. Improvements in pelvic support structures, such as POP-Q points Aa and Ba, were more marked in the intervention group. The clinical response rate (defined as a ≥ 4-point improvement in ICIQ-SF) was 68.3% in the intervention group, significantly higher t","PeriodicalId":11975,"journal":{"name":"European journal of obstetrics, gynecology, and reproductive biology","volume":"319 ","pages":"Article 114987"},"PeriodicalIF":1.9,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146131574","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Successful management of early-diagnosed cervical pregnancy with suction curettage alone: A case series 单纯吸刮术成功治疗早期诊断的宫颈妊娠:一个病例系列。
IF 1.9 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2026-03-01 Epub Date: 2026-01-30 DOI: 10.1016/j.ejogrb.2026.114978
Tatsuya Arakaki, Ryu Matsuoka, Yuriko Yagi, Hiroko Takita, Yuka Yamashita, Mayumi Kaneko, Akihiko Sekizawa
{"title":"Successful management of early-diagnosed cervical pregnancy with suction curettage alone: A case series","authors":"Tatsuya Arakaki,&nbsp;Ryu Matsuoka,&nbsp;Yuriko Yagi,&nbsp;Hiroko Takita,&nbsp;Yuka Yamashita,&nbsp;Mayumi Kaneko,&nbsp;Akihiko Sekizawa","doi":"10.1016/j.ejogrb.2026.114978","DOIUrl":"10.1016/j.ejogrb.2026.114978","url":null,"abstract":"","PeriodicalId":11975,"journal":{"name":"European journal of obstetrics, gynecology, and reproductive biology","volume":"319 ","pages":"Article 114978"},"PeriodicalIF":1.9,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146099745","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
MRI in the incarceration of the gravid uterus: From diagnosis to individualized management MRI在妊娠子宫嵌顿中的应用:从诊断到个体化治疗
IF 1.9 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2026-03-01 Epub Date: 2026-01-26 DOI: 10.1016/j.ejogrb.2026.114975
Qianshi Zheng, Yu Zou

Background

Incarceration of the gravid uterus (IGU) is a rare but serious obstetric condition that demands precise diagnosis for optimal management.

Objectives

To evaluate the value of MRI in the diagnosis and individualized management of IGU.

Methods

We retrospectively analyzed six patients with IGU admitted to the institution from November 2022 and September 2025. Clinical data like gravidity and parity, gestational weeks of diagnosis and delivery, clinical management and pregnancy outcomes. Imaging findings from MRI and ultrasound were compared, including assessment of cervical elongation, placental position, and complications. The correlation between MRI-measured parameters and pregnancy outcomes was explored.

Results

MRI clearly demonstrated typical signs of IGU, including uterine retroversion and anterior cervical displacement. No significant difference was found between MRI and ultrasound in measuring cervical elongation (9.6 ± 4.5 cm vs 7.6 ± 4.2 cm, p = 0.393). MRI additionally enabled assessment of cervical thinning (0.4 ± 0.1 cm) and identified one case of placenta previa missed by ultrasound. Based on MRI findings, four cases underwent successful manual reduction or knee-chest positioning. A preliminary correlation was observed between anterior lower uterine segment thickness and fetal birth weight (r = 1.000, p = 0.020), though this requires validation in larger studies.

Conclusions

MRI provides accurate diagnosis and objective assessment of IGU and its complications, serving as a crucial adjunct to ultrasound. Incorporating MRI into the standardized clinical management pathway offers essential evidence for developing individualized treatment strategies.
背景:妊娠子宫淤塞(IGU)是一种罕见但严重的产科疾病,需要精确诊断以获得最佳治疗。目的探讨MRI在IGU诊断和个体化治疗中的价值。方法回顾性分析2022年11月至2025年9月收治的6例IGU患者。临床数据,如妊娠和胎次、诊断和分娩的妊娠周数、临床管理和妊娠结局。比较MRI和超声的影像学表现,包括评估宫颈伸长、胎盘位置和并发症。探讨mri测量参数与妊娠结局的相关性。结果smri清晰显示IGU的典型征象,包括子宫后倾和宫颈前移位。MRI与超声测量宫颈伸长无显著差异(9.6±4.5 cm vs 7.6±4.2 cm, p = 0.393)。此外,MRI还能评估宫颈变薄(0.4±0.1 cm),并发现1例超声未发现的前置胎盘。根据MRI结果,4例患者成功进行了手动复位或膝胸定位。初步观察到子宫前下段厚度与胎儿出生体重之间存在相关性(r = 1.000, p = 0.020),但这需要在更大规模的研究中进行验证。结论smri对IGU及其并发症的诊断准确、客观,是超声的重要辅助手段。将MRI纳入标准化的临床管理途径,为制定个性化的治疗策略提供了必要的证据。
{"title":"MRI in the incarceration of the gravid uterus: From diagnosis to individualized management","authors":"Qianshi Zheng,&nbsp;Yu Zou","doi":"10.1016/j.ejogrb.2026.114975","DOIUrl":"10.1016/j.ejogrb.2026.114975","url":null,"abstract":"<div><h3>Background</h3><div>Incarceration of the gravid uterus (IGU) is a rare but serious obstetric condition that demands precise diagnosis for optimal management.</div></div><div><h3>Objectives</h3><div>To evaluate the value of MRI in the diagnosis and individualized management of IGU.</div></div><div><h3>Methods</h3><div>We retrospectively analyzed six patients with IGU admitted to the institution from November 2022 and September 2025. Clinical data like gravidity and parity, gestational weeks of diagnosis and delivery, clinical management and pregnancy outcomes. Imaging findings from MRI and ultrasound were compared, including assessment of cervical elongation, placental position, and complications. The correlation between MRI-measured parameters and pregnancy outcomes was explored.</div></div><div><h3>Results</h3><div>MRI clearly demonstrated typical signs of IGU, including uterine retroversion and anterior cervical displacement. No significant difference was found between MRI and ultrasound in measuring cervical elongation (9.6 ± 4.5 cm vs 7.6 ± 4.2 cm, p = 0.393). MRI additionally enabled assessment of cervical thinning (0.4 ± 0.1 cm) and identified one case of placenta previa missed by ultrasound. Based on MRI findings, four cases underwent successful manual reduction or knee-chest positioning. A preliminary correlation was observed between anterior lower uterine segment thickness and fetal birth weight (r = 1.000, p = 0.020), though this requires validation in larger studies.</div></div><div><h3>Conclusions</h3><div>MRI provides accurate diagnosis and objective assessment of IGU and its complications, serving as a crucial adjunct to ultrasound. Incorporating MRI into the standardized clinical management pathway offers essential evidence for developing individualized treatment strategies.</div></div>","PeriodicalId":11975,"journal":{"name":"European journal of obstetrics, gynecology, and reproductive biology","volume":"319 ","pages":"Article 114975"},"PeriodicalIF":1.9,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146076485","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Obturator nerve injury during robot-assisted laparoscopic pelvic lymphadenectomy: Literature review and case series 机器人辅助腹腔镜盆腔淋巴结切除术中闭孔神经损伤:文献回顾和病例系列。
IF 1.9 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2026-03-01 Epub Date: 2026-01-29 DOI: 10.1016/j.ejogrb.2026.114981
O.P. Van Marle, J.P. Hoogendam, R.P. Zweemer, C.G. Gerestein

Objective

To describe a case series of patients with obturator nerve injury following pelvic lymphadenectomy (PLND) at the study centre, and provide a narrative review of the literature regarding the incidence, management and clinical course of obturator nerve injury after PLND.

Methods

A literature search was performed using PubMed and Google Scholar, applying the terms ‘obturator nerve injury’ and ‘lymph node dissection’, including relevant MeSH terms and synonyms. In addition, all patients with obturator nerve injury following robot-assisted laparoscopic PLND at the study centre between 1 January 2008 and 31 December 2023 were identified. Data regarding type of surgery, surgical repair technique, materials used, and postoperative course were collected. The primary outcome was recovery of motor and sensory function. Secondary outcomes included residual morbidity, the proportion of patients achieving full recovery within 1 year, and the need for additional surgical intervention.

Results

In total, 16 patients with obturator nerve injury following PLND were identified. In most cases, a primary end-to-end epineural anastomosis using 5–0 or 6–0 Prolene sutures was performed. In five patients, a primary anastomosis was not feasible, and nerve grafts or polyglycolic acid/collagen conduits were used. The majority of patients achieved full recovery within 3 months.

Conclusion

Obturator nerve injury is a rare complication of PLND. In most cases, primary end-to-end epineural repair can be performed to restore nerve continuity, and this is associated with a favourable clinical course. While most patients recover within 3 months, residual motor deficits may persist in a subset of cases. These findings should be interpreted as descriptive, as comparative evidence regarding surgical techniques and materials remains limited.
目的:报道研究中心盆腔淋巴结切除术(PLND)后闭孔神经损伤患者的病例系列,并对有关PLND后闭孔神经损伤的发生率、处理和临床病程的文献进行叙述性回顾。方法:使用PubMed和谷歌Scholar进行文献检索,使用术语“闭孔神经损伤”和“淋巴结清扫”,包括相关MeSH术语和同义词。此外,在2008年1月1日至2023年12月31日期间,所有在研究中心进行机器人辅助腹腔镜PLND后出现闭孔神经损伤的患者都被确定。收集手术类型、手术修复技术、所用材料及术后病程等资料。主要结果是运动和感觉功能的恢复。次要结局包括残余发病率、1年内完全康复的患者比例以及是否需要额外的手术干预。结果:共发现16例PLND术后闭孔神经损伤。在大多数情况下,采用5-0或6-0 Prolene线进行初级端到端神经外吻合术。在5例患者中,一期吻合不可行,神经移植或聚乙醇酸/胶原导管被使用。大多数患者在3个月内完全康复。结论:闭孔神经损伤是少见的PLND并发症。在大多数情况下,可以进行初级端到端神经外修复以恢复神经连续性,这与良好的临床病程有关。虽然大多数患者在3个月内康复,但部分病例可能持续存在残余运动缺陷。这些发现应该被解释为描述性的,因为关于手术技术和材料的比较证据仍然有限。
{"title":"Obturator nerve injury during robot-assisted laparoscopic pelvic lymphadenectomy: Literature review and case series","authors":"O.P. Van Marle,&nbsp;J.P. Hoogendam,&nbsp;R.P. Zweemer,&nbsp;C.G. Gerestein","doi":"10.1016/j.ejogrb.2026.114981","DOIUrl":"10.1016/j.ejogrb.2026.114981","url":null,"abstract":"<div><h3>Objective</h3><div>To describe a case series of patients with obturator nerve injury following pelvic lymphadenectomy (PLND) at the study centre, and provide a narrative review of the literature regarding the incidence, management and clinical course of obturator nerve injury after PLND.</div></div><div><h3>Methods</h3><div>A literature search was performed using PubMed and Google Scholar, applying the terms ‘obturator nerve injury’ and ‘lymph node dissection’, including relevant MeSH terms and synonyms. In addition, all patients with obturator nerve injury following robot-assisted laparoscopic PLND at the study centre between 1 January 2008 and 31 December 2023 were identified. Data regarding type of surgery, surgical repair technique, materials used, and postoperative course were collected. The primary outcome was recovery of motor and sensory function. Secondary outcomes included residual morbidity, the proportion of patients achieving full recovery within 1 year, and the need for additional surgical intervention.</div></div><div><h3>Results</h3><div>In total, 16 patients with obturator nerve injury following PLND were identified. In most cases, a primary end-to-end epineural anastomosis using 5–0 or 6–0 Prolene sutures was performed. In five patients, a primary anastomosis was not feasible, and nerve grafts or polyglycolic acid/collagen conduits were used. The majority of patients achieved full recovery within 3 months.</div></div><div><h3>Conclusion</h3><div>Obturator nerve injury is a rare complication of PLND. In most cases, primary end-to-end epineural repair can be performed to restore nerve continuity, and this is associated with a favourable clinical course. While most patients recover within 3 months, residual motor deficits may persist in a subset of cases. These findings should be interpreted as descriptive, as comparative evidence regarding surgical techniques and materials remains limited.</div></div>","PeriodicalId":11975,"journal":{"name":"European journal of obstetrics, gynecology, and reproductive biology","volume":"319 ","pages":"Article 114981"},"PeriodicalIF":1.9,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146099782","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Systematic literature review and meta-analysis of postoperative complications of surgical management of vulvar cancer: what is the impact of frailty factors? 外阴癌手术治疗术后并发症的系统文献回顾和荟萃分析:虚弱因素的影响是什么?
IF 1.9 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2026-03-01 Epub Date: 2026-01-27 DOI: 10.1016/j.ejogrb.2026.114974
E. Raimond , C. Mimoun , I. Menouer , O. Graesslin , A. Fauconnier , C. Huchon

Introduction

Vulvar cancer surgery is associated with high rates of morbidity. Preventing or minimizing these morbidities is an important objective, as they impact on patients’ quality of life, and are highly deleterious in frail, aged patients, who represent the majority of those affected by this disease. This systematic literature review and meta-analysis assesses post-operative complications in vulvar cancer surgery, and attempts to identify the impact of frailty factors.

Method

A Pubmed search was conducted to identify studies reporting data on complications of vulvar cancer surgery in frail patients, from January 2000 to April 2022, following the recommendations of the PRISMA, and registered in PROSPERO (CRD 42024503036). The evaluation criteria were: age, frailty, and complications. Statistical heterogeneity of results was assessed by graphical representations of confidence intervals (CI) on forest plot and by a Chi2 heterogeneity test.

Result

Frailty related to age > 70 years increases the risk of inguinal disunion (OR = 1.89, 95%CI [1.12–3.20]). Frailty (due to age and obesity) does not increase the risk of lymphocele. Frailty factors, such as obesity, are risk factors for inguinal cellulitis (OR = 1.86, 95%CI [1.12–3.08]), and diabetes is a risk factor for inguinal infection.

Conclusion

This literature review and meta-analysis precludes drawing any significant clinical conclusion regarding the impact of frailty, in particular age-related frailty, on the occurrence of complications. This is due to different definitions of complications, a lack of precision in the data provided, the variety of surgical techniques performed, the absence of an age group or a frailty group.
外阴癌手术与高发病率相关。预防或尽量减少这些发病率是一项重要目标,因为它们影响患者的生活质量,并且对体弱的老年患者非常有害,而这些患者占该疾病患者的大多数。本系统的文献综述和荟萃分析评估了外阴癌手术后并发症,并试图确定虚弱因素的影响。方法:根据PRISMA的建议,检索2000年1月至2022年4月期间报告虚弱患者外阴癌手术并发症的研究,并在PROSPERO (CRD 42024503036)中注册。评价标准为:年龄、体弱、并发症。通过森林样地置信区间(CI)的图形表示和Chi2异质性检验来评估结果的统计异质性。结果与70岁相关的衰弱增加了腹股沟不愈合的风险(OR = 1.89, 95%CI[1.12-3.20])。虚弱(由于年龄和肥胖)不会增加淋巴囊肿的风险。肥胖等虚弱因素是腹股沟蜂窝织炎的危险因素(OR = 1.86, 95%CI[1.12-3.08]),糖尿病是腹股沟感染的危险因素。本文献综述和荟萃分析排除了关于虚弱,特别是与年龄相关的虚弱对并发症发生影响的任何重要临床结论。这是由于并发症的定义不同,所提供的数据缺乏准确性,所采用的手术技术多种多样,缺乏年龄组或虚弱组。
{"title":"Systematic literature review and meta-analysis of postoperative complications of surgical management of vulvar cancer: what is the impact of frailty factors?","authors":"E. Raimond ,&nbsp;C. Mimoun ,&nbsp;I. Menouer ,&nbsp;O. Graesslin ,&nbsp;A. Fauconnier ,&nbsp;C. Huchon","doi":"10.1016/j.ejogrb.2026.114974","DOIUrl":"10.1016/j.ejogrb.2026.114974","url":null,"abstract":"<div><h3>Introduction</h3><div>Vulvar cancer surgery is associated with high rates of morbidity. Preventing or minimizing these morbidities is an important objective, as they impact on patients’ quality of life, and are highly deleterious in frail, aged patients, who represent the majority of those affected by this disease. This systematic literature review and meta-analysis assesses post-operative complications in vulvar cancer surgery, and attempts to identify the impact of frailty factors.</div></div><div><h3>Method</h3><div>A Pubmed search was conducted to identify studies reporting data on complications of vulvar cancer surgery in frail patients, from January 2000 to April 2022, following the recommendations of the PRISMA, and registered in PROSPERO (CRD 42024503036). The evaluation criteria were: age, frailty, and complications. Statistical heterogeneity of results was assessed by graphical representations of confidence intervals (CI) on forest plot and by a Chi2 heterogeneity test.</div></div><div><h3>Result</h3><div>Frailty related to age &gt; 70 years increases the risk of inguinal disunion (OR = 1.89, 95%CI [1.12–3.20]). Frailty (due to age and obesity) does not increase the risk of lymphocele. Frailty factors, such as obesity, are risk factors for inguinal cellulitis (OR = 1.86, 95%CI [1.12–3.08]), and diabetes is a risk factor for inguinal infection.</div></div><div><h3>Conclusion</h3><div>This literature review and meta-analysis precludes drawing any significant clinical conclusion regarding the impact of frailty, in particular age-related frailty, on the occurrence of complications. This is due to different definitions of complications, a lack of precision in the data provided, the variety of surgical techniques performed, the absence of an age group or a frailty group.</div></div>","PeriodicalId":11975,"journal":{"name":"European journal of obstetrics, gynecology, and reproductive biology","volume":"319 ","pages":"Article 114974"},"PeriodicalIF":1.9,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146076482","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neonatal encephalopathy requiring therapeutic hypothermia over 5 years in a national Irish birth cohort: Relevance of the obstetric data 在爱尔兰全国出生队列中,5年以上需要低温治疗的新生儿脑病:产科数据的相关性。
IF 1.9 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2026-03-01 Epub Date: 2026-01-29 DOI: 10.1016/j.ejogrb.2026.114982
Aenne Helps , Indra Lazaro Campillo , Paul Corcoran , Julie McGinley , Richard Greene , John Murphy , Peter McKenna
<div><div><strong>Background</strong>: Neonatal encephalopathy, often due to peripartum hypoxia–ischemia, remains a significant cause of neonatal morbidity and mortality. Therapeutic hypothermia is the established treatment for moderate and severe neonatal encephalopathy in Ireland since 2012 after publication of an international trial. Despite adherence to strict clinical criteria, the maternal and obstetric factors associated with infants requiring therapeutic hypothermia remain incompletely understood.</div><div><strong>Objectives</strong>: To describe maternal and infant characteristics among infants treated with therapeutic hypothermia in Ireland over five years, and to assess whether obstetric factors are associated with increased risk of neonatal encephalopathy.</div><div><strong>Study design</strong>: A population-based, retrospective cohort study of all infants (n = 357) who received therapeutic hypothermia in Ireland from 2016 to 2020 was conducted. Data were collected from 19 maternity units and compiled into a national register. The study compared antenatal and intrapartum characteristics between therapeutic hypothermia cases and the national birthing population. Risks per 1,000 births and their exact Poisson 95% confidence intervals and risk ratios (RR) and their 95% CI were the primary statistical measures reported.</div><div><strong>Results</strong>: The incidence of therapeutic hypothermia was 1.18 per 1,000 live births (357/301,442), with some evidence of increase over time (RR for 2020 vs 2016 = 1.36, CI: 0.98–1.90; p = 0.068). Infants born to nulliparous women had a more than twofold higher risk of receiving therapeutic hypothermia (1.79 vs 0.80 per 1,000; RR = 2.25, CI: 1.82–2.77; p < 0.001). Therapeutic hypothermia risk increased significantly with maternal obesity (RR = 1.65) and fetal growth restriction (RR = 2.74 for < 3rd centile; RR = 1.99 for 4th–10th centile). Emergency caesarean section was associated with the highest therapeutic hypothermia risk. Sentinel events such as shoulder dystocia (n = 42; 11.8%), placental abruption (n = 20; 5.6%), and uterine rupture (n = 12; 3.4%) were significantly associated with therapeutic hypothermia (shoulder dystocia RR = 17.48, CI: 12.67–24.12; p < 0.001). Overall, 14% (50/357) of infants died. Among those followed up with Bayley-III testing (n = 85), 21.2% had motor, 16.5% cognitive, and 28.2% language delays.</div><div><strong>Conclusion:</strong> Infants born to nulliparous women, those exposed to maternal obesity, fetal growth restriction and emergency caesarean section birth were at increased risk of requiring therapeutic hypothermia. Sentinel events, while strongly associated with therapeutic hypothermia, were infrequent, suggesting cumulative or dynamic perinatal factors play a critical role. These findings underscore the importance of enhanced intrapartum monitoring and structured clinical response systems to reduce avoidable neonatal encephalopathy cases in Ireland
背景:新生儿脑病,通常是由于围产期缺氧缺血,仍然是新生儿发病率和死亡率的一个重要原因。自2012年发表一项国际试验以来,治疗性低温是爱尔兰中度和重度新生儿脑病的既定治疗方法。尽管遵守严格的临床标准,与婴儿需要治疗性低温相关的产妇和产科因素仍然不完全清楚。目的:描述爱尔兰五年来接受治疗性低温治疗的婴儿的母婴特征,并评估产科因素是否与新生儿脑病风险增加相关。研究设计:对2016年至2020年在爱尔兰接受治疗性低温的所有婴儿(n = 357)进行了一项基于人群的回顾性队列研究。从19个产科单位收集数据并汇编成国家登记册。该研究比较了治疗性低温病例和全国分娩人群的产前和产时特征。每1000个新生儿的风险及其确切的泊松95%置信区间和风险比(RR)及其95% CI是报告的主要统计指标。结果:治疗性低温的发生率为每1000例活产1.18例(357/ 301442),有证据表明随着时间的推移会增加(2020年与2016年的RR = 1.36, CI: 0.98-1.90; p = 0.068)。无产妇女所生的婴儿接受治疗性低温治疗的风险高出两倍多(1.79 vs 0.80 / 1000; RR = 2.25, CI: 1.82-2.77; p)结论:无产妇女所生的婴儿,暴露于母亲肥胖、胎儿生长受限和紧急剖腹产分娩的婴儿需要治疗性低温治疗的风险增加。前哨事件,虽然与治疗性低温密切相关,但并不常见,表明累积或动态围产期因素起关键作用。这些发现强调了加强产时监测和结构化临床反应系统的重要性,以减少爱尔兰可避免的新生儿脑病病例。
{"title":"Neonatal encephalopathy requiring therapeutic hypothermia over 5 years in a national Irish birth cohort: Relevance of the obstetric data","authors":"Aenne Helps ,&nbsp;Indra Lazaro Campillo ,&nbsp;Paul Corcoran ,&nbsp;Julie McGinley ,&nbsp;Richard Greene ,&nbsp;John Murphy ,&nbsp;Peter McKenna","doi":"10.1016/j.ejogrb.2026.114982","DOIUrl":"10.1016/j.ejogrb.2026.114982","url":null,"abstract":"&lt;div&gt;&lt;div&gt;&lt;strong&gt;Background&lt;/strong&gt;: Neonatal encephalopathy, often due to peripartum hypoxia–ischemia, remains a significant cause of neonatal morbidity and mortality. Therapeutic hypothermia is the established treatment for moderate and severe neonatal encephalopathy in Ireland since 2012 after publication of an international trial. Despite adherence to strict clinical criteria, the maternal and obstetric factors associated with infants requiring therapeutic hypothermia remain incompletely understood.&lt;/div&gt;&lt;div&gt;&lt;strong&gt;Objectives&lt;/strong&gt;: To describe maternal and infant characteristics among infants treated with therapeutic hypothermia in Ireland over five years, and to assess whether obstetric factors are associated with increased risk of neonatal encephalopathy.&lt;/div&gt;&lt;div&gt;&lt;strong&gt;Study design&lt;/strong&gt;: A population-based, retrospective cohort study of all infants (n = 357) who received therapeutic hypothermia in Ireland from 2016 to 2020 was conducted. Data were collected from 19 maternity units and compiled into a national register. The study compared antenatal and intrapartum characteristics between therapeutic hypothermia cases and the national birthing population. Risks per 1,000 births and their exact Poisson 95% confidence intervals and risk ratios (RR) and their 95% CI were the primary statistical measures reported.&lt;/div&gt;&lt;div&gt;&lt;strong&gt;Results&lt;/strong&gt;: The incidence of therapeutic hypothermia was 1.18 per 1,000 live births (357/301,442), with some evidence of increase over time (RR for 2020 vs 2016 = 1.36, CI: 0.98–1.90; p = 0.068). Infants born to nulliparous women had a more than twofold higher risk of receiving therapeutic hypothermia (1.79 vs 0.80 per 1,000; RR = 2.25, CI: 1.82–2.77; p &lt; 0.001). Therapeutic hypothermia risk increased significantly with maternal obesity (RR = 1.65) and fetal growth restriction (RR = 2.74 for &lt; 3rd centile; RR = 1.99 for 4th–10th centile). Emergency caesarean section was associated with the highest therapeutic hypothermia risk. Sentinel events such as shoulder dystocia (n = 42; 11.8%), placental abruption (n = 20; 5.6%), and uterine rupture (n = 12; 3.4%) were significantly associated with therapeutic hypothermia (shoulder dystocia RR = 17.48, CI: 12.67–24.12; p &lt; 0.001). Overall, 14% (50/357) of infants died. Among those followed up with Bayley-III testing (n = 85), 21.2% had motor, 16.5% cognitive, and 28.2% language delays.&lt;/div&gt;&lt;div&gt;&lt;strong&gt;Conclusion:&lt;/strong&gt; Infants born to nulliparous women, those exposed to maternal obesity, fetal growth restriction and emergency caesarean section birth were at increased risk of requiring therapeutic hypothermia. Sentinel events, while strongly associated with therapeutic hypothermia, were infrequent, suggesting cumulative or dynamic perinatal factors play a critical role. These findings underscore the importance of enhanced intrapartum monitoring and structured clinical response systems to reduce avoidable neonatal encephalopathy cases in Ireland","PeriodicalId":11975,"journal":{"name":"European journal of obstetrics, gynecology, and reproductive biology","volume":"319 ","pages":"Article 114982"},"PeriodicalIF":1.9,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146104498","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Expression of concern "A randomized comparison of a single-incision needleless (Contasure-needleless®) mini-sling versus a mid-urethral sling (Contasure-KIM®): 60-month follow-up results". [Eur. J. Obstet. Gynecol. Reprod. Biol. 307C (2025) 7-12]. “单切口无针(contasure - needeless®)迷你吊带与中尿道吊带(Contasure-KIM®)的随机比较:60个月的随访结果”。(欧元。j .。。Gynecol。天线转换开关。生物工程学报,2015(5):357 - 357。
IF 1.9 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2026-03-01 Epub Date: 2026-01-18 DOI: 10.1016/j.ejogrb.2026.114971
Ozan Dogan, Pinar Kadirogullari, Erhan Huseyin Comert, Alper Basbug, Murat Yassa
{"title":"Expression of concern \"A randomized comparison of a single-incision needleless (Contasure-needleless®) mini-sling versus a mid-urethral sling (Contasure-KIM®): 60-month follow-up results\". [Eur. J. Obstet. Gynecol. Reprod. Biol. 307C (2025) 7-12].","authors":"Ozan Dogan, Pinar Kadirogullari, Erhan Huseyin Comert, Alper Basbug, Murat Yassa","doi":"10.1016/j.ejogrb.2026.114971","DOIUrl":"10.1016/j.ejogrb.2026.114971","url":null,"abstract":"","PeriodicalId":11975,"journal":{"name":"European journal of obstetrics, gynecology, and reproductive biology","volume":"319 ","pages":"114971"},"PeriodicalIF":1.9,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146776288","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Umbilical cord diameter and cross-sectional area in association with gestational age among women with uncomplicated pregnancies in north-central Nigeria: a cross-sectional study 尼日利亚中北部无并发症妊娠妇女脐带直径和横断面积与胎龄的关系:一项横断研究
IF 1.9 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2026-03-01 Epub Date: 2026-01-27 DOI: 10.1016/j.ejogrb.2026.114976
Musa A. Muslimah , Halimat J. Akande , Hadijat O. Raji , Bola B. Olafimihan , Latifat T. Aremu , James I. Owolabi , Sadiya M. Gwadabe , Idris O. Quadri

Aim and objectives

To assess gestational age using the umbilical cord diameter (UCD) and cross-sectional area (CSA).

Methodology

This was a cross-sectional study among 300 women with no adverse medical history and uncomplicated pregnancies between the 14th and 40th completed weeks of pregnancy. The commonly used foetal parameters for gestational age (GA) estimation: Biparietal Diameter, Head and Abdominal Circumference and Femur Length were measured using standard protocols.
UCD and CSA were measured in a plane adjacent to cord insertion into the foetal abdomen within 1 cm. UCD was measured in long axis from outer-to-outer border of the umbilical cord using the electronic calipers. The cross-sectional area was obtained in transverse axis using the ellipse measurement and area was calculated automatically by the ultrasound machine in-built software. Measurements were taken twice for each parameter, and the average value was recorded for each participant to reduce intra-observer error.

Result

The mean UCD and CSA were 16.12 ± 4.28 mm and 2.08 ± 0.87 cm2 respectively. UCD and CSA were observed to increase steadily with GA up to the 33rd week of gestation, decline and then remain stable from the 38th and 39th week gestation respectively until the end of pregnancy. Significant correlations (p = 0.001) between umbilical cord diameter and cross-sectional area with estimated foetal weight (EFW), GA and other foetal parameters for GA estimation was observed.
A regression analysis model between UCD, CSA and GA showed 95% confidence interval (CI). GA by LMP (weeks) = 1.528 (UCD) + 2.646, 7.544 (CSA) + 11.540. GA by US (weeks) = 1.542 (UCD) + 2.653, 7.618 (CSA) + 11.619.

Conclusion

UCD and CSA measurement is a reliable method for prediction of GA and has a strong linear relationship with commonly used foetal parameters.
目的和目的利用脐带直径(UCD)和横断面积(CSA)来评估胎龄。这是一项横断面研究,研究对象为300名在妊娠第14周至第40周之间无不良病史和无并发症妊娠的妇女。胎龄(GA)估计常用的胎儿参数:采用标准方案测量双顶骨直径、头腹围和股骨长度。UCD和CSA在胎儿腹部脐带止点附近1 cm内测量。利用电子卡尺从脐带外到外沿长轴测量UCD。横轴截面积采用椭圆测量法获得,面积由超声机内置软件自动计算。每个参数测量两次,并记录每个参与者的平均值,以减少观察者内部误差。结果平均UCD为16.12±4.28 mm, CSA为2.08±0.87 cm2。UCD和CSA在妊娠33周前随GA稳步上升,在妊娠38周和39周后分别下降并保持稳定,直至妊娠结束。脐带直径和横断面积与估计胎儿体重(EFW)、GA和用于估计GA的其他胎儿参数之间存在显著相关(p = 0.001)。UCD、CSA和GA之间的回归分析模型显示95%可信区间(CI)。GA的LMP(周)= 1.528 (UCD) + 2.646, 7.544 (CSA) + 11.540。由我们GA(周)= 1.542 (UCD) + 2.653, 7.618 (CSA) + 11.619。结论ucd和CSA测定是预测GA的可靠方法,与常用胎儿参数有较强的线性关系。
{"title":"Umbilical cord diameter and cross-sectional area in association with gestational age among women with uncomplicated pregnancies in north-central Nigeria: a cross-sectional study","authors":"Musa A. Muslimah ,&nbsp;Halimat J. Akande ,&nbsp;Hadijat O. Raji ,&nbsp;Bola B. Olafimihan ,&nbsp;Latifat T. Aremu ,&nbsp;James I. Owolabi ,&nbsp;Sadiya M. Gwadabe ,&nbsp;Idris O. Quadri","doi":"10.1016/j.ejogrb.2026.114976","DOIUrl":"10.1016/j.ejogrb.2026.114976","url":null,"abstract":"<div><h3>Aim and objectives</h3><div>To assess gestational age using the umbilical cord diameter (UCD) and cross-sectional area (CSA).</div></div><div><h3>Methodology</h3><div>This was a cross-sectional study among 300 women with no adverse medical history and uncomplicated pregnancies between the 14th and 40th completed weeks of pregnancy. The commonly used foetal parameters for gestational age (GA) estimation: Biparietal Diameter, Head and Abdominal Circumference and Femur Length were measured using standard protocols.</div><div>UCD and CSA were measured in a plane adjacent to cord insertion into the foetal abdomen within 1 cm. UCD was measured in long axis from outer-to-outer border of the umbilical cord using the electronic calipers. The cross-sectional area was obtained in transverse axis using the ellipse measurement and area was calculated automatically by the ultrasound machine in-built software. Measurements were taken twice for each parameter, and the average value was recorded for each participant to reduce intra-observer error.</div></div><div><h3>Result</h3><div>The mean UCD and CSA were 16.12 ± 4.28 mm and 2.08 ± 0.87 cm<sup>2</sup> respectively. UCD and CSA were observed to increase steadily with GA up to the 33rd week of gestation, decline and then remain stable from the 38th and 39th week gestation respectively until the end of pregnancy. Significant correlations (p = 0.001) between umbilical cord diameter and cross-sectional area with estimated foetal weight (EFW), GA and other foetal parameters for GA estimation was observed.</div><div>A regression analysis model between UCD, CSA and GA showed 95% confidence interval (CI). GA by LMP (weeks) = 1.528 (UCD) + 2.646, 7.544 (CSA) + 11.540. GA by US (weeks) = 1.542 (UCD) + 2.653, 7.618 (CSA) + 11.619.</div></div><div><h3>Conclusion</h3><div>UCD and CSA measurement is a reliable method for prediction of GA and has a strong linear relationship with commonly used foetal parameters.</div></div>","PeriodicalId":11975,"journal":{"name":"European journal of obstetrics, gynecology, and reproductive biology","volume":"319 ","pages":"Article 114976"},"PeriodicalIF":1.9,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146076414","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Which body region’s fat accumulation increase the risk of stress urinary incontinence? 哪个身体部位的脂肪堆积会增加压力性尿失禁的风险?
IF 1.9 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2026-03-01 Epub Date: 2026-01-19 DOI: 10.1016/j.ejogrb.2026.114957
Ana Jéssica dos Santos Sousa , Stela Márcia Mattiello , Ana Paula Rodrigues Rocha , Alessander Danna-Dos-Santos , Patricia Driusso
The objective of this cross-sectional study was to examine the association between fat mass distribution and stress urinary incontinence (SUI) symptoms, as well as the impact of SUI on daily activities. We assessed sociodemographic characteristics, urinary symptoms, and fat mass (total, android, gynoid, and visceral adipose tissue [VAT]). Descriptive statistics, independent t tests, and univariable and multivariable regression analyses were conducted. Women with SUI exhibited significantly higher total, android, gynoid, and VAT fat mass than women without urinary incontinence (p < 0.05). Increases in total, android, gynoid, and VAT fat mass were associated with higher odds of SUI by 0.4%, 4.4%, 2.6%, and 31.4%, respectively. VAT fat mass was particularly influential, increasing the likelihood of SUI by 51% (odds ratio [OR] 1.51; 95% CI). Greater VAT accumulation was also associated with a 16.0% increase in discomfort related to urinary symptoms and a 9.3% increase in the impact on daily activities among women with SUI. In summary, higher adiposity in the android, gynoid, and especially VAT regions are associated with an increased likelihood of SUI and with greater symptom-related discomfort and functional impact.
本横断面研究的目的是探讨脂肪质量分布与压力性尿失禁(SUI)症状之间的关系,以及SUI对日常活动的影响。我们评估了社会人口学特征、泌尿系统症状和脂肪量(总脂肪、安卓脂肪、雌核脂肪和内脏脂肪组织[VAT])。进行描述性统计、独立t检验、单变量和多变量回归分析。SUI患者的总脂肪量、android脂肪量、gynoid脂肪量和VAT脂肪量明显高于无尿失禁的女性(p < 0.05)。总脂肪量、安卓脂肪量、雌核脂肪量和增值脂肪量的增加分别与SUI的高发生率相关,分别为0.4%、4.4%、2.6%和31.4%。增值脂肪量的影响特别大,使SUI的可能性增加51%(优势比[OR] 1.51; 95% CI)。在患有SUI的女性中,较大的VAT积累还与与泌尿系统症状相关的不适增加16.0%和对日常活动的影响增加9.3%相关。综上所述,android, gyoid,特别是VAT区域的高脂肪与SUI的可能性增加以及更大的症状相关的不适和功能影响相关。
{"title":"Which body region’s fat accumulation increase the risk of stress urinary incontinence?","authors":"Ana Jéssica dos Santos Sousa ,&nbsp;Stela Márcia Mattiello ,&nbsp;Ana Paula Rodrigues Rocha ,&nbsp;Alessander Danna-Dos-Santos ,&nbsp;Patricia Driusso","doi":"10.1016/j.ejogrb.2026.114957","DOIUrl":"10.1016/j.ejogrb.2026.114957","url":null,"abstract":"<div><div>The objective of this cross-sectional study was to examine the association between fat mass distribution and stress urinary incontinence (SUI) symptoms, as well as the impact of SUI on daily activities. We assessed sociodemographic characteristics, urinary symptoms, and fat mass (total, android, gynoid, and visceral adipose tissue [VAT]). Descriptive statistics, independent t tests, and univariable and multivariable regression analyses were conducted. Women with SUI exhibited significantly higher total, android, gynoid, and VAT fat mass than women without urinary incontinence (p &lt; 0.05). Increases in total, android, gynoid, and VAT fat mass were associated with higher odds of SUI by 0.4%, 4.4%, 2.6%, and 31.4%, respectively. VAT fat mass was particularly influential, increasing the likelihood of SUI by 51% (odds ratio [OR] 1.51; 95% CI). Greater VAT accumulation was also associated with a 16.0% increase in discomfort related to urinary symptoms and a 9.3% increase in the impact on daily activities among women with SUI. In summary, higher adiposity in the android, gynoid, and especially VAT regions are associated with an increased likelihood of SUI and with greater symptom-related discomfort and functional impact.</div></div>","PeriodicalId":11975,"journal":{"name":"European journal of obstetrics, gynecology, and reproductive biology","volume":"319 ","pages":"Article 114957"},"PeriodicalIF":1.9,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146076470","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An individual participant data network meta-analysis of the APOSTEL trials on the effect of tocolysis in threatened preterm birth between 30–33+6 weeks of gestation in twin pregnancies APOSTEL试验的个体参与者数据网络荟萃分析,研究了在双胎妊娠30-33+6周的先兆早产中使用缩胎治疗的效果。
IF 1.9 4区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2026-03-01 Epub Date: 2026-02-03 DOI: 10.1016/j.ejogrb.2026.114989
L. van Gils , L.I. van der Windt , A.H. van Kaam , C. Roos , E. Pajkrt , M.A. Oudijk

Objective

Twin pregnancies have a substantial risk of preterm birth, but evidence on tocolytics is limited. We evaluated whether nifedipine or atosiban improves neonatal outcomes compared with placebo.

Design

Individual participant data network meta-analysis (IPD-NMA) of two international multicentre randomised controlled trials (APOSTEL 3 and 8).

Setting

The APOSTEL-3 compared nifedipine with atosiban, while the APOSTEL-8 compared atosiban with placebo.

Population

Women with twin pregnancies and threatened preterm birth between 30+0 and 33+6 weeks.

Methods

Analyses were performed at the infant level using generalised estimating equations to account for clustering within twin pairs.

Main outcome measures

Adverse neonatal outcome: composite of neonatal morbidity or mortality.

Results

A total of 179 women were included: 94 allocated to atosiban, 27 to nifedipine, and 58 to placebo. Prolongation beyond 48 h was not significantly increased with nifedipine (RR 0.96, 95% CI 0.68–1.36) or atosiban (RR 1.10, 95% CI 0.88–1.38). The composite adverse neonatal outcome occurred in 3.7% of neonates in the nifedipine group (2/54), 7.5% in the atosiban group (14/188), and 5.2% in the placebo group (6/116). Relative risks were 0.72 (95% CI 0.15–3.43) for nifedipine vs placebo, 1.44 (95% CI 0.57–3.64) for atosiban vs placebo, and 2.01 (95% CI 0.47–8.58) for atosiban vs nifedipine.

Conclusion

No clear benefit of nifedipine or atosiban over placebo on neonatal outcomes in twin pregnancies with threatened preterm birth between 30+0 and 33+6 weeks was found.
目的:双胎妊娠有很大的早产风险,但关于早产的证据有限。我们评估了硝苯地平或阿托西班与安慰剂相比是否能改善新生儿结局。设计:两项国际多中心随机对照试验(APOSTEL 3和8)的个体参与者数据网络荟萃分析(IPD-NMA)。设置:APOSTEL-3比较硝苯地平和阿托西班,APOSTEL-8比较阿托西班和安慰剂。人群:30+0 ~ 33+6周的双胎妊娠和有早产危险的妇女。方法:在婴儿水平上进行分析,使用广义估计方程来解释双胞胎中的聚类。主要结局指标:新生儿不良结局:新生儿发病率或死亡率的综合。结果:共纳入179名妇女:94名分配给阿托西班,27名分配给硝苯地平,58名分配给安慰剂。硝苯地平组(RR 0.96, 95% CI 0.68-1.36)或阿托西班组(RR 1.10, 95% CI 0.88-1.38)未显著增加48 h以上的延长时间。硝苯地平组新生儿复合不良结局发生率为3.7%(2/54),阿托西班组为7.5%(14/188),安慰剂组为5.2%(6/116)。硝苯地平与安慰剂的相对危险度为0.72 (95% CI 0.15-3.43),阿托西班与安慰剂的相对危险度为1.44 (95% CI 0.57-3.64),阿托西班与硝苯地平的相对危险度为2.01 (95% CI 0.47-8.58)。结论:硝苯地平或阿托西班对30+0 ~ 33+6周双胎先兆早产的新生儿结局没有明显优于安慰剂。
{"title":"An individual participant data network meta-analysis of the APOSTEL trials on the effect of tocolysis in threatened preterm birth between 30–33+6 weeks of gestation in twin pregnancies","authors":"L. van Gils ,&nbsp;L.I. van der Windt ,&nbsp;A.H. van Kaam ,&nbsp;C. Roos ,&nbsp;E. Pajkrt ,&nbsp;M.A. Oudijk","doi":"10.1016/j.ejogrb.2026.114989","DOIUrl":"10.1016/j.ejogrb.2026.114989","url":null,"abstract":"<div><h3>Objective</h3><div>Twin pregnancies have a substantial risk of preterm birth, but evidence on tocolytics is limited. We evaluated whether nifedipine or atosiban improves neonatal outcomes compared with placebo.</div></div><div><h3>Design</h3><div>Individual participant data network <em>meta</em>-analysis (IPD-NMA) of two international multicentre randomised controlled trials (APOSTEL 3 and 8).</div></div><div><h3>Setting</h3><div>The APOSTEL-3 compared nifedipine with atosiban, while the APOSTEL-8 compared atosiban with placebo.</div></div><div><h3>Population</h3><div>Women with twin pregnancies and threatened preterm birth between 30<sup>+0</sup> and 33<sup>+6</sup> weeks.</div></div><div><h3>Methods</h3><div>Analyses were performed at the infant level using generalised estimating equations to account for clustering within twin pairs.</div></div><div><h3>Main outcome measures</h3><div>Adverse neonatal outcome: composite of neonatal morbidity or mortality.</div></div><div><h3>Results</h3><div>A total of 179 women were included: 94 allocated to atosiban, 27 to nifedipine, and 58 to placebo. Prolongation beyond 48 h was not significantly increased with nifedipine (RR 0.96, 95% CI 0.68–1.36) or atosiban (RR 1.10, 95% CI 0.88–1.38). The composite adverse neonatal outcome occurred in 3.7% of neonates in the nifedipine group (2/54), 7.5% in the atosiban group (14/188), and 5.2% in the placebo group (6/116). Relative risks were 0.72 (95% CI 0.15–3.43) for nifedipine <em>vs</em> placebo, 1.44 (95% CI 0.57–3.64) for atosiban <em>vs</em> placebo, and 2.01 (95% CI 0.47–8.58) for atosiban <em>vs</em> nifedipine.</div></div><div><h3>Conclusion</h3><div>No clear benefit of nifedipine or atosiban over placebo on neonatal outcomes in twin pregnancies with threatened preterm birth between 30<sup>+0</sup> and 33<sup>+6</sup> weeks was found.</div></div>","PeriodicalId":11975,"journal":{"name":"European journal of obstetrics, gynecology, and reproductive biology","volume":"319 ","pages":"Article 114989"},"PeriodicalIF":1.9,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146131544","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
European journal of obstetrics, gynecology, and reproductive biology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1